Brief: Infant Bacterial Therapeutics Q1 Oper Loss At SEK 17.5 Mln
07/05/2025 13:32
May 7 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST: INFANT BACTERIAL THERAPEUTICS AB - REPORTS OPERATING INCOME OF KSEK -17,495 FOR Q1 2025 Source text: ID:nMFN2CYjHh Further company coverage: [IBTb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln